Pharmacologic Approaches to Reperfusion Injury

Advances in Pharmacology

Volumn 39, Issue C, 1997, Pages 291-312

  Willerson, James T ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; MONOCLONAL ANTIBODY; NITRIC OXIDE; SELECTIN;

ANIMAL; HEART ARRHYTHMIA; HUMAN; IMMUNOLOGY; METABOLISM; REPERFUSION INJURY; REVIEW; STUNNED HEART MUSCLE;

ADENOSINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIOXIDANTS; ARRHYTHMIA; CALCIUM CHANNEL BLOCKERS; FREE RADICALS; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; NITRIC OXIDE; SELECTINS;

EID: 0030634193     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60074-5     Document Type: Article

References (126)

1. Ambrosio G., Villari B., and Chiariello M. Calcium antagonists and experimental myocardial ischemic reperfusion. J. Cardiovasc. Pharmacol. 20 Suppl. 7 (1992) S26-S29
2. Bando K., Tago M., and Teramoto S. Prevention of free radical induced myocardial injury by allopurinol. J. Thorac. Surg. 95 (1988) 465-473
3. Becker B.F., Reinholz N., Ozcelik T., Leipert B., and Gerlach E. Uric acid as radical scavenger and antioxidant in the heart. Pfluegers Arch. 415 (1989) 127-135
4. Bednar M., Smith B., Pinto A., and Mullane K. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ. Res. 57 (1985) 131-141
5. Berneir M., Hearse D., and Manning A. Ability of 6 anti-free radical interventions to reduce reperfusion-induced arrhythmias caused by addition of a free radical generating system. J. Mol. Cell. Cardiol. 18 (1986) 100
6. Biaggioni I., Killian T.J., Mosqueda-Garcia R., and Robertson R.M. Adenosine increases sympathetic nerve traffic in humans. Circulation 83 (1991) 1668-1675
7. Blann A., Midgley H., Burrows G., Maxwell S., Utting S., Davies M., Waite M., and McCollum C. Free radicals, antioxidants and endothelial cell damage after percutaneous transluminal coronary angioplasty. Coronary Artery Dis. 4 (1993) 905-910
8. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview. Cardiovasc. Drugs Ther. 5 Suppl.2 (1991) 249-268
9. Bolli R., Patel B.S., Jeroudi M.D., Lai E.K., and McCay P.B. Demonstration of free radical generation in"stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-Butyl nitrone. J. Clin. Invest. 82 (1988) 476-485
10. Braunwald E., and Kloner R.A. Myocardial reperfusion: A double edged sword. J. Clin. Invest. 76 (1985) 1713-1719
11. Buerke M., Weyrich A.S., Zheng Z., Gaeta F.C., Forrest M.J., and Lefer A.M. Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 3 (1994) 1140-1148
12. Coombs V.J., Black L., and Townsend S.N. Myocardial reperfusion injury: The critical challenge. Crit. Care Nurs. Clin. North Am. 4 (1992) 339-346
13. Cox D.A., Vita J.A., Treasure C.B., Fish R.D., Selwyn A.P., and Ganz P. Reflex increase in blood pressure during the intracoronary administration of adenosine in man. J. Clin. Invest. 84 (1989) 592-596
14. DiPierro F.V., Neely C.F., Kong M., and Gardner T.J. A1 Adenosine receptor antagonists reduce ischemia/reperfusion injury in a feline heart regional infarct model. Circulation 92 (1995) 1-513 (Abstr. No. 2446)
15. Dore M., Hawkins H.K., Entman M.L., and Smith C.W. Production of a monoclonal antibody against canine GMP-140 (P-selectin) and studies of its vascular distribution in canine tissues. Vet. Pathol. 30 (1993) 213-222
16. Dore M., Korthuis R.J., Granger D.N., Entman M.L., and Smith C.W. P-selectin mediates spontaneous leukocyte rolling in vivo. Blood 82 (1993) 1308-1316
17. Dore M., Simon S.I., Hughes B.J., Entman M.L., and Smith C.W. P-selectin-and CD18-mediated recruitment of canine neutrophils under conditions of shear stress. Vet. Pathol. 32 (1995) 258-268
18. Downey J.M. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu. Rev. Physiol. 52 (1990) 487-504
19. Dusting G.J. Nitric oxide in cardiovascular disorders. J. Vasc. Res. 32 (1995) 143-161
20. Dusting G.J., and MacDonald P.S. Endogenous nitric oxide in cardiovascular disease and transplantation. Ann. Med. 27 (1995) 395-406
21. Emerit I., Fabiani J.-N., Ponzio O., Murday A., Lunel F., and Carpentier A. Clastogenic factor in ischemia-reperfusion injury during open-heart surgery; protective effect of allopurinol. Ann. Thorac. Surg. 46 (1988) 619-624
22. Emerit I., Faviani J.-N., Ponzio O., Murday A., Lunel F., and Carpentier A. Clastogenic factor in ischemia-reperfusion injury during open-heart surgery: Protective effect of allopurinol. Ann. Thorac. Surg. 60 (1995) 736-737
23. Emerit I., Faviani J.-N., Ponzio O., Murday A., Lunel F., and Carpentier A. Free radicals, reperfusion and myocardial infarction therapy: European Myocardial Infarction Project-Free Radicals Pilot Study. Eur. Heart J. 14 Suppl. G (1993) 48-51 EMIP-FR Pilot Study Group
24. Engler R., and Covell J. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ. Res. 61 (1987) 20-28
25. Entman M.L., Youker K., Shoji T., Kukielka G., Shappell S.B., Taylor A.A., and Smith C.W. Neutrophil-induced oxidative injury of cardiac myocytes. A compartmented system requiring CDllb/CD18-ICAM-l adherence. J. Clin. Invest. 90 (1992) 1335-1345
26. Fabiani J.N., Farah B., Vuilleminot A., Lecompte T., Emerit I., Chardigny C., and Carpentier A. Chromosomal aberrations and neutrophil activation induced by reperfusion in the ischaemic human heart. Eur. Heart J. 14 Suppl G (1993) 12-17
27. Fishbein M.C. Reperfusion injury. Clin. Cardiol. 13 (1990) 213-217
28. Flaherty J., and Weisfeldt M. Reperfusion injury. Free Radical Biol. Med. 5 (1988) 409
29. Flaherty J.T., Weisfeldt M.D., Bulkley B.H., Gardner T.J., Gott V.L., and Jacobus W.E. Mechanisms of ischemic myocardial cell damage assessed by phorphorus 31 nuclear magnetic resonance. Circulation 65 (1982) 561-571
30. Forman M.B., Puett D.W., Cates C.U., McCroskey D.E., Beckman J.K., Greene H.L., and Virmani R. Glutathione redox pathway and reperfusion injury: Effect of Nacerylcysteine on infarct size and ventricular function. Circulation 78 (1988) 202-213 [comment in Circulation 80, 712-713(1989)]
31. Fox K.A.A. Reperfusion injury: Laboratory phenomenon or clinical reality. Cardiovasc. Res. 26 (1992) 656-659
32. Gimpel J.A., Lahpor J.R., van der Molen A.-J., Damen J., and Hitchcock J.F. Reduction of reperfusion injury of human myocardium by allopurinol: A clinical study. Free Radical Biol. Med. 19 (1995) 251-255
33. Greenberg S., and Frishman W.H. Coenzyme A10: A new drug for cardiovascular disease. J. Clin. Pharmacol. 30 (1990) 596-608
34. Grum C.M., Ketai L.H., Meyers C.L., and Schlafer M. Purine reflux after cardiac ischemia: Relevance to allopurinol cardioprotection. Am. J. Physiol. 252 (1987) H368-H373
35. Guerci A.D., Gerstenblith G., Brinker J.A., Chandra N.C., Gottlieb S.O., Bahr R.D., Weiss J.L., Shapiro E.P., Flaherty J.T., and Bush D.W. Arandomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N. Engl. J. Med. 317 (1987) 1613-1618
36. Hashimoto K., Pearson P.J., Schaff H.V., and Carrier R. Endothelial cell dysfunction after ischemic arrest and reperfusion. A possible mechanism of myocardial injury during reflow. J. Thorac. Cardiovasc. Surg. 102 (1991) 688-694
37. Hearse D.J. Reperfusion of the ischemic myocardium. J. Mol. Cell. Cardiol. 9 (1977) 605-616
38. Hess M.L., and Kukreja R.C. Free radicals, calcium homeostasis, heat shock proteins and myocardial stunning. Ann. Thorac. Surg. 60 (1995) 760-766
39. Hudson K.F. A phenomenon of paradox: myocardial reperfusion injury. Heart Lung 23 (1994) 384-393
40. Janero D.R. Therapeutic potential of vitamin E against myocardial ischemicreperfusion injury. Free Radical Biol. Med. 10 (1991) 315
41. Janero D.R. Myocardial ischemia-reperfusion injury and the cardioprotective potential of natural antioxidants. In: Frei B. (Ed). "Natural Antioxidants in Human Health and Disease" (1994), Academic press, San Diego, CA 411
42. Janero D.R. Ischemic heart disease and antioxidants: Mechanistic aspects of oxidative injury and its prevention. Crit. Rev. Food Sci. Nut. 35 (1995) 65-81
43. Janero D.R., Hreniuk D., and Sharif H.M. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): Nonperoxidative purine and pyrimidine nucleotide depletion. J. Cell. Physiol. 155 (1993) 494
44. Jeroudi M.O., Triana F.J., Patel B.S., and Bolli R. Effect of superoxide dismutase and catalase, given separately, on myocardial "stunning.". Am. J. Physiol. 259 (1990) H889-H901
45. Jeroudi M.O., Hartley C.J., and Bolli R. Myocardial reperfusion injury: Role of oxygen radicals with potential therapy with antioxidants. Am. J. Cardiol. 73 (1994) 2B-7B
46. Jolly S.R., Kane W.J., Bailie M.D., Abrams G.D., and Lucchesi B.R. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ. Res. 54 (1984) 277-285
47. Juggi J.S., Koenig-Berard E., and Van Gilst W.H. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors. [Review]. Can. J. Cardiol. 9 (1993) 336-352
48. Karmazyn M. The 1990 Merck Forsst Award. Ischemic and reperfusion injury in the heart. Cellular mechansims and pharmacological interventions. Can. J. Physiol. Pharmacol. 69 (1991) 719-730
49. Katoh S., Toyama J., Kodama I., Akita T., and Abe T. Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischemia-reperfusion. J. Mol. Cell. Cardiol. 24 (1993) 1267-1275
50. Kitakaze M., Takashima S., and Sato H. Stimulation of adenosine A1 and A2 receptors prevents myocardial stunning. Circulation 82 (1990) III-37 (abstr.)
51. Kitakaze M., Hori M., Sato H., Iwakura K., Gotoh K., Inoue M., Kitabatake A., and Kamada T. Beneficial effects of alpha, adrenoceptor activity on myocardial stunning in dogs. Circ. Res. 68 (1991) 1322-1339
52. Kitakaze M., Hori M., and Kamada T. Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium. Cardiovasc. Res. 27 (1993) 18-27
53. Kloner R.A. Does reperfusion injury exist in humans. J. Am. Coll. Cardiol. 21 (1993) 537-545
54. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54 (1974) 1496-1508
55. Kloner R.A., Ganote C.E., Whalen D., and Jennings R.B. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow. Am. J. Pathol. 74 (1974) 399-422
56. Kloner R.A., Ellis S.G., Lange R., and Braunwald E. Studies of experimental coronary artery reperfusion: Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvasculai- damage. Circulation 68 Suppl. 1 (1983) 8-15
57. Kloner R.A., Przyklenk K., and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation 80 (1989) 1115-1127
58. Konya L., Kekesi V., Juhasz-Nagy S., and Feher J. The effect of superoxide dismutase in the myocardium during reperfusion in the dog. Free Radical Biol. Med. 13 (1992) 527
59. Korthuis R.J., and Granger D.N. Reactive oxygen metabolites, neutrophils and the pathogenesis of ischemic-tissue/reperfusion. Clin. Cardiol. 16 1, Suppl. 1 (1993) 119-126
60. Kukielka G.L., Smith C.W., Manning A.M., Youker K.A., Michael L.H., and Entman M.L. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92 (1995) 1866-1875
61. Lasley R.D., and Mentzer Jr. R.M. Protective effects of adenosine in the reversibly injured heart. Ann. Thorac. Surg. 60 (1995) 843-846
62. Lazzarino G., Tavazzi B., DiPierro D., and Giardina B. Ischemia and reperfusion: Effect of fructose-l,6-biphosphate. Free Radical Res. Commun. 16 (1992) 325-329
63. Lee K.C., Horan P.J., Canniff P.C., Silver P.J., and Ezrin A.M. Myocardial salvage by Trolox and ascorbic acid, but not ascorbic acid alone, in anesthetized dogs and rabbits. Drug Dev. Res. 27 (1992) 345
64. Lefer A.M. Role of selectins in myocardial ischemia-reperfusion injury. Ann. Thorac. Surg. 60 (1995) 773-777
65. Lefer A.M. Attenuation of myocardial ischemia-reperfusion injury with nitric acid replacement therapy. Ann. Thorac. Surg. 60 (1995) 847-851
66. Lefer A.M. Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion. New Horizons 3 (1995) 105-112
67. Lefer A.M., Tsao P.S., Lefer D.J., and Ma X. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 5 (1991) 2029-2034
68. Lefer D.J., Flynn D.M., Phillips L., Ratcliffe M., and Buja A.J. A novel sialyl Lewisx analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 90 (1994) 2390-2401
69. Lo H.-M., Kloner R.A., and Braunwald E. Effect of intracoronary verapamil on infarct size in the ischemic reperfused canine heart: Critical importance of the timing of treatment. Am. J. Cardiol. 56 (1985) 672-677
70. Lucchesi B., and Mullane K. Leukocytes and ischemia-induced myocardial injury. Annu. Rev. Pharmacol. Toxicol. 26 (1986) 201-224
71. Ma X., Weyrich A.S., Lefer D.J., Buerke M., Albertine K.H., Kishimoto T.K., and Lefer A.M. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 88 (1993) 649-658
72. Manning A., and Hearse D. Reperfusion-induced arrhythmias: Mechanisms and prevention. J. Mol. Cell. Cardiol. 16 (1984) 497-518
73. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., and Ignarro L.J. Role of L-argninine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262 (1992) H616-H620
74. Mazer C.D. Calcium and stunned myocardium. J. Cardiac Surg. 8 2 Suppl (1993) 329-331
75. Meldrum D.R., Mitchell M.B., Banerjee A., and Harken A.H. Cardiac preconditioning. Induction of endogenous tolerance to ischemia-reperfusion injury. Arch. Surg. (Chicago) 128 (1993) 1208-1211
76. Menasche P., Grousset C., Gauduel Y., Mouas C., and Piwnica A. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardi-oplegic protection. J. Thorac. Cardiovasc. Surg. 103 (1992) 936
77. Mickle D.A., and Weisel R.D. Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. Can. J. Cardiol. 9 (1993) 89-93 [see comment in Can. J. Cardiol. 9, 29-31(1993) J
78. Mullane K., Read N., Salmon J., and Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 228 (1984) 510-522
79. Myers M.L., Bolli R., Lekich R.F., Hartley C.J., and Roberts R. Enhancements of recovery of mycoardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 72 (1985) 915-921
80. Nakanishi K., Zhao Z.-Q., Vinten-Johansen J.H., Lewis J.C., McGee D.S., and Hammon Jr. J.W. Coronary artery endothelial dysfunction after ischemia, blood cardi-oplegia and reperfusion. Ann. Thorac. Surg. 58 (1994) 191-199
81. Naseem S.A., Kontos M.C., Rao P.S., Jesse R.L., Hess M.L., and Kukreja R.C. Sustained inhibition of nitric oxide by N G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated rat heart. J. Mol. Cell. Cardiol. 27 (1995) 419-426
82. Nayler W.G., and Elz J.S. Reperfusion injury: Laboratory artifact or clinical dilemma. Circulation 74 (1986) 215-221
83. Neely C.F., and Keith I.M. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am. J. Physiol. 268 (1995) L1036-L1046
84. Nejima J., Knight D.R., Fallon J.T., Uemura N., Manders W.T., Canfield D.R., Cohen M.V., and Vatner S.F. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional myocardial function or myocardium at risk in conscious dogs. Circulation 79 (1989) 143-153
85. Nicolini F., Mehta J., Nichols Luostarinen W.I.R., and Saldeen T. Leukocyte elastase inhibition and t-PA-induced coronary artery thrombolysis in dogs;- Beneficial effects on myocardial histology. Am. Heart J. 122 (1991) 1245-1251
86. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation 80 (1989) 1049-1062
87. Park J.W., Braum P., Mertens S., and Heinrich K.W. Ischemic reperfusion injury and restenosis after coronary angioplasty. Ann. N.Y. Acad. Sci. 669 (1992) 215-236
88. Patel B.S., Jeroudi M.O., O'Neill P.G., Roberts R., and Bolli R. Effect of human recombinant superoxide dismutase on canine myocardial infarction. Am. J. Physiol. 258 (1990) H369-H380 (2 Pt 2)
89. Peters H.J., and Koehler H. Selenium and lipid peroxidation in human and experimental cardiovascular disease. In: Miguel J., Quintanilha A.T., Quintanilha A.T., and Weber H. (Eds). "CRC Handbook of Free Radicals and Antioxidants in Biomedicine." 2 (1989), CRC Press, Boca Raton, FL 237
90. Przyklenk K., and Kloner R.A. Superoxide dismutase plus catalase improve contractile function in the canine model of the stunned myocardium. Circ. Res. 58 (1986) 148-156
91. Przyklenk K., and Kloner R.A. Effect of verapamil on postischemic "stunned" myocardium: Importance of timing of treatment. J. Am. Coll. Cardiol. 11 (1988) 614-623
92. Przyklenk K., Ghafari B.G., Eitzman D.T., and Kloner R.A. Nifedipine administered after reperfusion ablasts systolic contractile dysfunction of postischemic "stunned" myocardium. J. Am. Coll. Cardiol. 13 (1989) 1176-1183
93. Przyklenk K., Whittaker P., and Kloner R.A. Zofenopril, a newly developed sulfhydryl-containing converting enzyme inhibitor, enhances contractile function of "stunned" myocardium. In: MacGregor G.A., and Sever P.S. (Eds). "Current Advances in Ace Inhibition" (1989), Churchill-Livingstone, Edinburgh 279
94. Rao P.S., Lui X.K., Das D.K., Weinstein G.S., and Tyras D.H. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxi-dant. Ann. Thorac. Surg. 52 (1991) 908-912
95. Randhawa M.P., Lasley R.D., and Mentzer Jr. R.M. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J. Thorac. Cardiovasc. Surg. 112 (1996) 202-204
96. Reimer K.A., Lowe J.E., and Jennings R.B. Effect of calcium antagonist verapamil on necrosis following temporary coronary occlusion in dogs. Circulation 55 (1977) 581-590
97. Reznick A.Z., Kagan V.E., Ramsey R., Tsuchiya M., Khwaja S., Servinova E.A., and Packer L. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: The possible role of iron chelation. Arch. Biochem. Biophys. 296 (1992) 394-401
98. Romson J., Hook B., Kunel S., Abrams G., Schork M., and Lucchesi B. Reduction of the extent of ischemia myocardial injury by neutrophil depletion in the dog. Circulation 67 (1983) 1016-1023
99. Seccombe J.F., and Schaff H.V. Coronary artery endothelial function after myocardial ischemia and reperfusion (review). Ann. Thorac. Surg. 60 (1995) 778-788
100. Sekili S., Li X.Y., Zughayb M., Sun J.Z., and Bolli R. Evidence for a major pathogenetic role of hydroxyl radical in myocardial "stunning" in the conscious dog. Circulation 84 Suppl. 2 (1991) II-656
101. Silver M.J., Sutton J.M., Hook S., Lee P., Malycky J.L., Phillips L., Ellis S.G., Topol E.J., and Nicolini F.A. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation 92 (1995) 492-499
102. Simpson P., Mitsos S., Ventura A., Gallagher K., Fantone J., and Lucchesi B. Prostacyclin protects ischemic reperfusion myocardium in the dog by inhibition of neutrophil activation. Am. Heart J. 113 (1987) 129-137
103. Simpson P., Mickelson J., Fantone J., Gallagher K., and Lucchesi B. Reduction of experimental myocardial infarct size with prostaglandin E,-inhibition of neutrophil migration and activation. J. Pharmacol. Exp. Ther. 244 (1988) 619-624
104. Srimani B.N., Engelman R.M., Jones R., and Das D.K. Protective role of intracoronary fatty acid binding protein in ischemic and reperfused myocardium. Circ. Res. 66 (1990) 1535-1543
105. Taylor A.E., Golino P., Eckels R., Pastor P., Buja L.J., and Willerson J.T. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J. Am. Coll. Cardiol. 15 (1990) 737-747
106. Thiel M., and Bardenheuer H. Regulation of oxygen radical production of human poly-morphonuclear leukocytes by adenosine: The role of calcium. Pfluegers Arch. 420 (1992) 522
107. Triana J.F., Li X.-Y., Jamaluddin U., Thronby J.I., and Bolli R. Postischemic myocardial "stunning": Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ. Res. 69 (1991) 731-747
108. Tsao P.S., Aoki N., Lefer D.J., Johnson G., and Lefer III A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82 (1990) 1402-1412
109. Villari B., Ambrosio G., Golino P., Ragni M., and Chiariello M. Reduction of severity of ischemia decreases reperfusion injury in rabbit hearts. Eur. Heart J. 12 2 (1991) 136 (abstr.)
110. Vinten-Johansen J., and Nakanishi K. Postcardioplegia acute cardiac dysfunction and reperfusion injury. J. Cardiothorac. Vasc. Aneth. 7 4 (1993) 6-18 Suppl. 2
111. Vinten-Johansen J., Chiantella V., Faust K.B., Jonston W.E., McCain B., Hartman M., Mills S.A., Hester T.O., and Cordell A.R. Myocardial protection with blood cardioplegia in ischemically injured heart: Reduction of reoxigenation injury with allopurinol. Am. Thorac. Surg. 45 (1988) 319-326
112. Vinten-Johansen J., Zhao Z.-Q., and Sato H. Reduction in surgical ischemia-reperfusion injury with adenosine and nitric oxide therapy. Ann. Thorac. Surg. 60 (1995) 852-857
113. Werns S. Free radical scavengers and leukocyte inhibitors. In: Topol E.J. (Ed). "Textbook of Interventional Cardiology" 2 (1994), Saunders, Philadelphia 137-160
114. Werns S.W., Shea M.J., Mitsos S.E., Dysko R.C., Fantone J.C., Schort M.A., Abrams G.D., and Lucchesi B.R. Reduction of the size of infarction by allopurinol in the ischemic reperfused heart. Lab. Invest. 73 (1986) 518-524
115. Westlin W., and Mullane K. Does captopril attentuate reperfusion induced myocardial dysfunction by scavenging free radicals. Circulation 77 Suppl. 1 (1988) 30-39
116. Weyrich A.S., Ma X., and Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86 (1992) 279
117. Weyrich A.S., Ma X., Lefer D.J., Albertine K.H., and Lefer A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91 (1993) 2620-2629
118. Whalen D.A., Hamilton D.G., Ganote C.E., and Jennings R.B. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am. J. Pathol. 74 (1974) 381-398
119. White H.D. Reperfusion injury-a reply to Keith Fox. Cardiovasc. Res. 26 (1992) 660-661
120. Wiggers C.J. The interplay of coronary vascular resistance and myocardial compression in regulating coronary flow. Circ. Res. 2 (1954) 217-279
121. Willerson J.T., Watson J.T., Hutton I., Templeton G.H., and Fixler D.E. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ. Res. 36 (1975) 771-781
122. Wu T.W., Wu J., Li R.K., Mickle D., and Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem. Cell Biol. 639 (1991) 683-688
123. Yellon D.M., Hearse D.J., Maxwell M.P., Chambers D.E., and Downery J.M. Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: Verapamil infusion in dogs with small myocardial infarcts. Am. J. Cardiol. 51 (1983) 1409-1414
124. Youker K.A., Smith C.W., Anderson D.C., Miller D., Michael L.H., Rossen R.D., and Entman M.L. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion. J. Clin. Invest. 89 (1992) 602-609
125. Youker K.A., Hawkins H.K., Kukielka G.L., Perrard J.L., Michael L.H., Ballantyne C.M., Smith C.W., and Entman M.L. Molecular evidence for a border zone vulnerable to inflammatory reperfusion injury. Trans. Assoc. Am. Physicians 106 (1993) 145-154
126. Zucchi R., Poddighe R., Limbruno U., Mariani M., Ronca-Testoni S., and Ronca G. Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate. J. Mol. Cell. Cardiol. 21 (1989) 67-73